102 Then again, several teams are advocating with the incorporation of novel markers, like a complex karyotype55 or epigenetic subsets, 27,28 into medical follow. These novel prognostic and/or predictive versions will must be validated in cohorts of patients handled with specific brokers. Some degree of immunophenotype overlap amongst CLL, marginal https://situsjudimbl7721098.sharebyblog.com/31754546/the-2-minute-rule-for-mbl77